Mätlik K, Govek EE, Hatten ME (2025). Histone bivalency in CNS development Genes & Development
Hanzel M, Fernando K, Maloney SE, Horn Z, Gong S, Mätlik K, Zhao J, Pasolli HA, Heissel S, Dougherty JD, Hull C, Hatten ME (2024). Mice lacking Astn2 have ASD-like behaviors and altered cerebellar circuit properties Proceedings of the National Academy of Sciences, 121 (34): e2405901121
Feng L, Barrows D, Zhong L, Mätlik K, Porter EG, Djomo AM, Yau I, Soshnev AA, Carroll TS, Wen D, Hatten ME, Garcia BA, Allis CD (2023). Altered chromatin occupancy of patient-associated H4 mutants misregulate neuronal differentiation bioRxiv
Mätlik K, Govek EE, Paul MR, Allis CD, Hatten ME (2023). Histone bivalency regulates the timing of cerebellar granule cell development Genes & Development, 37 (13-14): 570-589
Mätlik K, Olfat S, Cowlishaw MC, Moreno ED, Ollila S, Andressoo JO (2023). In vivo modulation of endogenous gene expression via CRISPR/Cas9-mediated 3’UTR editing Heliyon, 9 (3): e13844
Mätlik K, Garton DR, Montaño-Rodríguez AR, Olfat S, Eren F, Casserly L, Damdimopoulos A, Panhelainen A, Porokuokka LL, Kopra JJ, Turconi G, Schweizer N, Bereczki E, Piehl F, Engberg G, Cervenka S, Piepponen TP, Zhang FP, Sipilä P, Jakobsson J, Sellgren CM, Erhardt S, Andressoo JO (2022). Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia Molecular Psychiatry, 27 (8): 3247-3261
Mätlik K, Võikar V, Vilenius C, Kulesskaya N, Andressoo JO (2018). Two-fold elevation of endogenous GDNF levels in mice improves motor coordination without causing side-effects Scientific Reports, 8 (1): 11861
Kopra JJ, Panhelainen A, af Bjerkén S, Porokuokka LL, Varendi K, Olfat S, Montonen H, Piepponen TP, Saarma M, Andressoo JO (2017). Dampened Amphetamine-Stimulated Behavior and Altered Dopamine Transporter Function in the Absence of Brain GDNF The Journal of Neuroscience, 37 (6): 1581-1590
Kumar A, Kopra JJ, Varendi K, Porokuokka LL, Panhelainen A, Kuure S, Marshall P, Karalija N, Härma MA, Vilenius C, Lilleväli K, Tekko T, Mijatovic J, Pulkkinen N, Jakobson M, Jakobson M, Ola R, Palm E, Lindahl M, Strömberg I, Võikar V, Piepponen TP, Saarma M, Andressoo JO (2015). GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function PLOS Genetics, 11 (12): e1005710
Kopra JJ, Vilenius C, Grealish S, Härma MA, Varendi K, Lindholm J, Castrén E, Võikar V, Björklund A, Piepponen TP, Saarma M, Andressoo JO (2015). GDNF is not required for catecholaminergic neuron survival in vivo Nature Neuroscience, 18 (3): 319-322
Varendi K, Mätlik K, Andressoo JO (2015). From microRNA target validation to therapy: lessons learned from studies on BDNF Cellular and Molecular Life Sciences, 72 (9): 1779-1794
Varendi K, Kumar A, Härma MA, Andressoo JO (2014). miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF Cellular and Molecular Life Sciences, 71 (22): 4443-4456
Varendi K, Airavaara M, Anttila J, Vose S, Planken A, Saarma M, Mitchell JR, Andressoo JO (2014). Short-term Preoperative Dietary Restriction Is Neuroprotective in a Rat Focal Stroke Model PLoS ONE, 9 (4): e93911
Full list of publications can be found here